Rovelizumab is a humanized monoclonal antibody that targets the leukointegrin family, specifically the CD11/CD18 cell adhesion proteins. This antibody is designed for the study of various inflammatory and ischemic conditions, including multiple sclerosis (MS), hemorrhagic shock, myocardial infarction (MI), and stroke. Rovelizumab's mechanism of action involves modulating leukocyte adhesion and migration, processes critical in the pathogenesis of these conditions. This makes Rovelizumab an essential tool for researchers investigating the cellular interactions and pathways underlying acute and chronic inflammatory responses.
Rovelizumab is a humanized monoclonal antibody that targets the leukointegrin family, specifically the CD11/CD18 cell adhesion proteins. This antibody is designed for the study of various inflammatory and ischemic conditions, including multiple sclerosis (MS), hemorrhagic shock, myocardial infarction (MI), and stroke. Rovelizumab's mechanism of action involves modulating leukocyte adhesion and migration, processes critical in the pathogenesis of these conditions. This makes Rovelizumab an essential tool for researchers investigating the cellular interactions and pathways underlying acute and chronic inflammatory responses.
This calculator helps you calculate mass of compound based on solution concentration, volume and molecular weight in a specific solution using the formula:
